Clinical Presentation & Management of Glomerular Diseases: Hematuria, Nephritic & Nephrotic Syndrome
Clinical Presentation & Management of Glomerular Diseases: Hematuria, Nephritic & Nephrotic Syndrome
Clinical Presentation & Management of Glomerular Diseases: Hematuria, Nephritic & Nephrotic Syndrome
Figure 1
relatively less common. This review will focus on summarizing common,
Glomerular Diseases glomerular diseases management in an out-patient set up.
Asymptomatic
Ȉ Proteinuria < 2gm/day Clinical Presentations
Ȉ Microscopic Hematuria > 2-3 The clinical presentation can vary from being asymptomatic to acutely
Ȉ Dysmorphic RBC/HPF
severe illness. See Figure 1. Specific history should include questioning
Gross Hematuria for early morning periorbital puffiness and evening time lower extremities
Ȉ No pain edema, foamy urine, and change in urine color, volume and/or odor. Systemic
Ȉ No blood clots
Ȉ Associated systemic infection diseases that are commonly associated with glomerular disease are diabetes,
hypertension, lupus, vasculitis, and viral infections like hepatitis B, C and
Rapidly Progressive
Ȉ Glomerulonephritis HIV 1,2,3. A positive family history of Alport’s syndrome in association with
Ȉ Renal failure hearing loss, uncommon forms of familial focal segmental glomerulosclerosis
Ȉ Sub-neprotic proteinuria
Ȉ Hematuria with RBC casts
(FSGS), or IgA disease is invaluable in arriving at a specific diagnosis. Certain
Ȉ Normal BP common drugs are associated with glomerular disease (See Table 1). Several
glomerulonephritis are preceded by acute streptococcal infection, infective
Nephrotic Syndrome
Ȉ Proteinuria > 3 gms/day endocarditis or viral infections. Frequently IgA nephropathy is brought
Ȉ Low serum Albumin < 3.5 gms/day to attention by hematuria caused by an acute systemic infection. Several
Ȉ Edema
Ȉ High lipids
malignancies are frequently associated with glomerular disease (See Table 2). It
is not uncommon for some malignancies to first manifest with renal problems.
Nephritic Syndrome Physical examination findings that point toward glomerular disease include
Ȉ Low urine output
Ȉ Hematuria with RBC casts dependent edema, periorbital edema, generalized anasarca, white nails, and
Ȉ Sub-nephrotic Proteinuria xanthelasmas pointing nephrotic syndrome, or pulmonary signs particularly
Ȉ High BP
hemorrhage suggestive of nephritic syndrome.
Chronic GN Urine examination findings are very critical in determining the direction
Ȉ Slowly progressive renal failure
Ȉ Hypertension
of further work up. Often urine findings of hematuria, proteinuria or both
Ȉ Normocytic Normochromic anemia may be the first sign of glomerular disease. Glomerular origin of RBCs is
Ȉ Secondary Hyperparathyroidism substantiated by findings of dysmorphic RBCs, acanthocytes, abnormal casts
and proteinuria. Presence of isolated monomorphic RBCs necessitates work-
up for lower urinary tract bleeding or lower urinary tract infection.
Table 1
Common Drugs Known to Cause
Glomerular Diseases Asymptomatic Mild Proteinuria
Normal proteinuria is less than 150 mg/day, which may contain up to
Minimal change disease: 20-30 mg of albumin. Non-nephrotic proteinuria is defined as a urine protein
Ȉ NSAIDs
Ȉ Interferon excretion of less than 3.5 gm/day or a random urine protein to creatinine
ratio of less than 3. Increased protein excretion is a hallmark of glomerular
Membranous GN:
Ȉ NSAIDs disease. When the urine dipstick for albumin is negative while the quantitative
Ȉ Penicillamine proteinuria is excessive suggests urinary excretion of light chain proteins.
Ȉ Mercury in skin lightening creams
Functional proteinuria is usually transient and is typically associated with
Focal Segmental Glomerulosclerosis: exercise and transient systemic illness. Orthostatic proteinuria occurs in
Ȉ Pamodronate children and young adults only in upright position and absent while recumbent
Ȉ Heroin
in absence of any identifiable secondary cause. Prognosis is uniformly good.
Hemolytic Uemic Syndrome: Stable asymptomatic non-nephrotic proteinuric patient with normal
Ȉ Cyclosporine
Ȉ Tacrolimus
kidney function is managed by close observation and a kidney biopsy is usually
Ȉ mitomycin C not indicated. However, presence of microscopic hematuria in association with
Ȉ Oral contraceptives a proteinuria though asymptomatic does change the prognosis and requires a
kidney biopsy.
severe and acute illnesses, such as rapidly progressive The nephrotic syndrome is defined by the presence
glomerulonephritis8 are the ones that have the most of heavy proteinuria (protein excretion greater than 3
benefit from aggressive immunosppressive management. g/24 hours), hypoalbuminemia (less than 3.0 g/dL), and
On the contrary, chronic GNs are rather resistant to peripheral edema. Hyperlipidemia and thrombotic disease
immunosuppression. Conditions where kidney biopsy may be present.
demonstrates extensive scarring, renal function is rapidly The nephritic syndrome is associated with hematuria
declining and is associated with anuria (urine output >200 and proteinuria and abnormal kidney function and
ml/day) should be managed conservatively because the carries poorer prognosis and is typically associated with
risk benefit ratio is unfavorable. Dialysis may be given as hypertension. The predominant cause of the nephrotic
needed. syndrome in children is minimal change disease. The most
As most immunosuppressive protocols are non-specific common causes of nephritic syndrome are post infectious
in nature, patients are heavily immunosuppressed and are GN, IgA nephropathy and lupus nephritis.
at risk for atypical infections. The major drugs that are Chronic GN is slowly progressive and is associated with
included in most protocols are corticosteroids azathioprine hypertension and gradual loss of kidney function. Treatment
and cyclophosphamide. Recently favorable results have been includes non-specific measure aimed at controlling
reported with drugs used in kidney transplant patients such hypertension, edema, proteinuria and disease modifying
as calcineurin inhibitors, mycophenalic acid and rapamycin. immunosuppression.
The nephrology community is slowly experimenting
drugs developed and used in oncology field, including References
rituximab. The literature reports of immunosuppressive 1. Braden, GL, Mulhern, JG, O’Shea, MH, et al. Changing incidence of
therapies are difficult to interpret and not easy to translate glomerular diseases in adults. Am J Kidney Dis 2000; 35:878.
in practice due to studies that consist of small number of 2. Malafronte, P, Mastroianni-Kirsztajn, G, Betônico, GN, et al. Paulista
Registry of glomerulonephritis: 5-year data report. Nephrol Dial Transplant
patients, lack of prospective randomized trials, variable 2006; 21:3098.
nature of GNs. 3. Heaf, J. The Danish Renal Biopsy Register. Kidney Int 2004; 66:895.
4. Wasserstein, AG. Membranous glomerulonephritis. J Am Soc Nephrol
1997; 8:664.
Summary
5. Crew, RJ, Radhakrishnan, J, Appel, G. Complications of the nephrotic
Because the differential diagnosis for GN is broad, syndrome and their treatment. Clin Nephrol 2004; 62:245.
using a classification schema is helpful to narrow the 6. Llach, F. Hypercoagulability, renal vein thrombosis, and other thrombotic
causes of GN in a systematic manner. The etiology of complications of nephrotic syndrome. Kidney Int 1985; 28:429.
glomerulonephritis can be classified by their clinical 7. Orth, SR, Ritz, E. The nephrotic syndrome. N Engl J Med 1998;
338:1202.
presentation (nephrotic, nephritic, rapidly progressive 8. Jennette, JC. Rapidly progressive crescentic glomerulonephritis. Kidney
GN, chronic GN) or by histopathology. GN may be Int 2003; 63:1164.
isolated to the kidney (primary glomerulonephritis)
or be a component of a systemic disorder (secondary Disclosure
glomerulonephritis). None reported. MM